Sulfoglycosphingolipids - Blood
Research News and Information

Monday, March 22, 2010

A variation in the cerebroside sulfotransferase gene is linked to exercise-modified insulin resistance and to type 2 diabetes.

3 Jul 2009 AIMS: The glycosphingolipid beta-galactosylceramide-3-O-sulfate (sulfatide) is present in the secretory granules of the insulin producing beta-cells and may act as a molecular chaperone of insulin. The final step in sulfatide synthesis is performed ... Read more...

Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.

25 Jul 2007 Sulfatides, normal components of serum lipoproteins, may play an important role in cardiovascular disease due to their various modulatory functions in haemostasis. The incidence of cardiovascular disease in patients with end-stage renal failure ... Read more...

Establishment of a quantitative, qualitative, and high-throughput analysis of sulfatides from small amounts of sera by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

18 Dec 2006 Based on our previous measurements of sulfatides, we further developed a quantitative, qualitative, and high-throughput analytical method for serum sulfatides as forms of lysosulfatides by matrix-assisted laser desorption ionization time-of-flight ... Read more...

Latest indexed articles for 'Sulfoglycosphingolipids - Blood'

These are the very latest articles for this heading:

• A variation in the cerebroside sulfotransferase gene is linked to exercise-modified insulin resistance and to type 2 diabetes. 3 Jul 2009
• Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. 25 Jul 2007
• Establishment of a quantitative, qualitative, and high-throughput analysis of sulfatides from small amounts of sera by matrix-assisted laser desorption ionization-time of flight mass spectrometry. 18 Dec 2006
• Low serum concentration of sulfatide and presence of sulfated lactosylceramid are associated with Type 2 diabetes. The Skaraborg Project. 30 Aug 2005
• Antibody-associated polyneuropathy syndromes: principles and treatment. 30 May 2003
• Contradictory functions of the sulfatide in the blood coagulation system. 30 Dec 2000
• Anti-sulfatide IgM antibodies in peripheral neuropathy. 13 Jun 2000
• A quantitative analysis of serum sulfatide by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction. 29 Sep 1999
• Alteration of acidic lipids in human sera during the course of pregnancy: characteristic increase in the concentration of cholesterol sulfate. 17 Dec 1997
• Serum autoantibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy. 29 Nov 1997
• Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen. 30 Mar 1996
• Sulphatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins and its anticoagulant activity. 29 Nov 1993
• The existence of galactosylceramide I3-sulfate in serums of various mammals and its anticoagulant activity. 30 Jul 1991
• Platelets adhere to sulfatides by von Willebrand factor dependent and independent mechanisms. 4 May 1991
• Glycosphingolipids of porcine blood: human blood group A and H antigens with type 1 chain in erythrocytes and plasma. 29 Nov 1990
• Occurrence of sulfatide as a major glycosphingolipid in WHHL rabbit serum lipoproteins. 29 Jun 1987
• The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. 3 Aug 1985
• Sulfatide role in the sodium pump. 30 Dec 1980
• The identification of sulphatides in human erythrocyte membrane and their relation to sodium-potassium dependent adenosine triphosphatase. 27 Feb 1978
• Free and sulfoconjugated dehydroepiandrosterone, cyclic adenosime-3',5'-monophosphate, and free estriol in maternal and cord blood. 13 Jan 1976

See a longer list of these articles.

Technical information about 'Sulfoglycosphingolipids'

Definition: GLYCOSPHINGOLIPIDS with a sulfate group esterified to one of the sugar groups.

Registry Number: 0

Descriptor UI: D013433

Alternative terms: Sulfoglycosphingolipids; Sulfatides; Sulfatoglycosphingolipids;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D09.400.410.420.025.837; D10.390.470.025.837; D10.570.877.360.025.837;

History Note: 99(71)